HUP0001441A2 - Eljárás 4-aza-androszt-1-én származékokat tartalmazó gyógyszerkészítmények előállítására - Google Patents

Eljárás 4-aza-androszt-1-én származékokat tartalmazó gyógyszerkészítmények előállítására

Info

Publication number
HUP0001441A2
HUP0001441A2 HU0001441A HUP0001441A HUP0001441A2 HU P0001441 A2 HUP0001441 A2 HU P0001441A2 HU 0001441 A HU0001441 A HU 0001441A HU P0001441 A HUP0001441 A HU P0001441A HU P0001441 A2 HUP0001441 A2 HU P0001441A2
Authority
HU
Hungary
Prior art keywords
androst
aza
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0001441A
Other languages
English (en)
Inventor
Tomowo Kobayashi
Koichi Kojima
Original Assignee
Sankyo Company, Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company, Limited filed Critical Sankyo Company, Limited
Publication of HUP0001441A2 publication Critical patent/HUP0001441A2/hu
Publication of HUP0001441A3 publication Critical patent/HUP0001441A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány az (I) általános képletű vegyületek -, a képletben R1 ésR2 egymástól függetlenül hidrogénatomot, hidroxilcsoportot, védetthidroxilcsoportot vagy rövid szénláncú alkoxicsoportot jelent -, vagygyógyászatilag elfogadható sóik vagy egyéb származékaik alkalmazásáravonatkozik prosztatarák elleni gyógyászati készítmények előállítására. Ó
HU0001441A 1997-02-26 1998-02-26 Process for the preparation of pharmaceutical compositions containing 4-aza-androst-1-ene derivatives HUP0001441A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4233597 1997-02-26
PCT/JP1998/000767 WO1998038207A1 (fr) 1997-02-26 1998-02-26 Compositions de traitement ou de prevention du cancer de la prostate

Publications (2)

Publication Number Publication Date
HUP0001441A2 true HUP0001441A2 (hu) 2000-10-28
HUP0001441A3 HUP0001441A3 (en) 2001-03-28

Family

ID=12633151

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001441A HUP0001441A3 (en) 1997-02-26 1998-02-26 Process for the preparation of pharmaceutical compositions containing 4-aza-androst-1-ene derivatives

Country Status (20)

Country Link
EP (1) EP0963998B1 (hu)
KR (1) KR20000075651A (hu)
CN (1) CN1131239C (hu)
AT (1) ATE265854T1 (hu)
AU (1) AU739308B2 (hu)
BR (1) BR9807767A (hu)
CA (1) CA2282836A1 (hu)
DE (1) DE69823650T2 (hu)
DK (1) DK0963998T3 (hu)
ES (1) ES2221703T3 (hu)
HK (1) HK1023576A1 (hu)
HU (1) HUP0001441A3 (hu)
ID (1) ID22762A (hu)
IL (1) IL131380A0 (hu)
NO (1) NO994107L (hu)
NZ (1) NZ337048A (hu)
PL (1) PL335365A1 (hu)
PT (1) PT963998E (hu)
RU (1) RU2196582C2 (hu)
WO (1) WO1998038207A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998930B1 (en) * 1997-07-29 2004-03-24 Sankyo Company Limited Azasteroid compound for treating alopecia, hirsutism and seborrhea
KR100698400B1 (ko) 2004-04-14 2007-03-23 이은주 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물
CA2562801C (en) 2004-04-14 2010-09-07 Eun-Joo Lee Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
EP1726650A1 (en) * 2005-05-27 2006-11-29 Universitätsklinikum Freiburg Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
RU2695348C2 (ru) * 2018-04-26 2019-07-23 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) Способ лечения больных с наличием метастазов в лимфатических узлах и олигометастазов в костях скелета при раке предстательной железы

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8505862D0 (en) * 1985-03-07 1985-04-11 Erba Farmitalia Steroidic 5alpha-reductase inhibitors
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
JPH06293793A (ja) * 1993-02-10 1994-10-21 Sankyo Co Ltd ステロイド−１７−アミド類の製造法
JPH0873492A (ja) * 1994-06-28 1996-03-19 Sankyo Co Ltd アザステロイド類
JPH0819151A (ja) * 1994-06-30 1996-01-19 Furukawa Electric Co Ltd:The アーマロッド巻付構造
CZ289856B6 (cs) * 1996-02-05 2002-04-17 Sankyo Company Limited Farmaceutický prostředek na bázi inhibitoru 5alfa-reduktázy
EP0998930B1 (en) * 1997-07-29 2004-03-24 Sankyo Company Limited Azasteroid compound for treating alopecia, hirsutism and seborrhea

Also Published As

Publication number Publication date
ES2221703T3 (es) 2005-01-01
NO994107D0 (no) 1999-08-25
NO994107L (no) 1999-08-25
AU739308B2 (en) 2001-10-11
CN1252805A (zh) 2000-05-10
ID22762A (id) 1999-12-09
NZ337048A (en) 2000-10-27
EP0963998B1 (en) 2004-05-06
CN1131239C (zh) 2003-12-17
DE69823650T2 (de) 2004-12-09
HUP0001441A3 (en) 2001-03-28
KR20000075651A (ko) 2000-12-26
WO1998038207A1 (fr) 1998-09-03
DK0963998T3 (da) 2004-08-16
PL335365A1 (en) 2000-04-25
BR9807767A (pt) 2000-02-22
EP0963998A4 (en) 2002-06-12
EP0963998A1 (en) 1999-12-15
CA2282836A1 (en) 1998-09-03
DE69823650D1 (de) 2004-06-09
IL131380A0 (en) 2001-01-28
PT963998E (pt) 2004-07-30
HK1023576A1 (en) 2000-09-15
RU2196582C2 (ru) 2003-01-20
AU6115998A (en) 1998-09-18
ATE265854T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
WO2005037825A3 (en) Protein kinase inhibitors
BR0014137A (pt) Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica
SE9904505D0 (sv) Novel compounds
YU23202A (sh) Lekovi za tretman malignih tumora
ATE316083T1 (de) Adamantanderivate
PL342614A1 (en) Anticarcinogenic drugs
HUP0001441A2 (hu) Eljárás 4-aza-androszt-1-én származékokat tartalmazó gyógyszerkészítmények előállítására
MXPA02012426A (es) Compuestos nuevos.
IL111725A0 (en) 3'-aziridino-anthracycline derivatives, their preparation and pharmaceutical compositions containing them
HUP0001845A2 (hu) Benzotiofénszármazékok alkalmazása emlőrák megelőzésére szolgáló gyógyszerkészítmények előállítására
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
HUP0003159A2 (hu) N-monoszubsztituált-3-oxo-4-aza-5alfa-androszt-1-én-17béta-karboxamidok alkalmazása gyógyászati készítmények előállítására
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
HUP9904402A2 (hu) Polihidroxi-fenol-származékok, alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
MXPA02001104A (es) Nuevos derivados citotoxicos de pirido[2,3,4-k1]acridina, su preparacion y su uso terapeutico.
HUP0202340A2 (hu) Hatóanyagként kondenzált heterociklusos vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
EE200200302A (et) Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid
AU2002359762A1 (en) Luminacin analogs and uses thereof
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.